ASP Isotopes Inc. (ASPI)

NASDAQ: ASPI · Real-Time Price · USD

8.93

-0.14 (-1.54%)

At close: Aug 1, 2025, 4:00 PM

8.90

-0.03 (-0.34%)

After-hours: Aug 1, 2025, 7:58 PM EDT

Revance Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	818	323	87	54	-
Market Cap Growth	67.80%	270.43%	60.83%	-	-
Enterprise Value	800	311	86	55	-
Last Close Price	8.93	4.53	1.79	1.58	-
PS Ratio	125.48	78.04	201.61	-	-
PB Ratio	15.14	6.32	4.64	5.53	-
P/TBV Ratio	20.84	7.23	6.70	5.53	-
EV/Sales Ratio	181.69	75.06	197.98	-	-
Debt / Equity Ratio	0.84	0.74	0.11	0.08	0.15
Asset Turnover	0.07	0.07	0.02	-	-
Quick Ratio	6.92	8.87	1.56	1.23	9.74
Current Ratio	7.21	9.31	1.85	1.71	10.62
Return on Equity (ROE)	-115.46%	-92.64%	-113.75%	-62.54%	-
Return on Assets (ROA)	-26.14%	-27.03%	-50.08%	-32.45%	-
Return on Capital (ROIC)	-29.36%	-29.98%	-63.43%	-36.29%	-
Earnings Yield	-4.48%	-10.00%	-18.66%	-9.11%	-
FCF Yield	-3.59%	-8.68%	-8.87%	-13.66%	-
Buyback Yield / Dilution	-67.66%	-68.36%	-23.41%	-64.92%	-

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q